CVAC
Price
$5.45
Change
-$0.02 (-0.37%)
Updated
Aug 6 closing price
Capitalization
1.23B
7 days until earnings call
VOR
Price
$2.08
Change
-$0.09 (-4.13%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
261.17M
One day until earnings call
Interact to see
Advertisement

CVAC vs VOR

Header iconCVAC vs VOR Comparison
Open Charts CVAC vs VORBanner chart's image
CureVac
Price$5.45
Change-$0.02 (-0.37%)
Volume$341.57K
Capitalization1.23B
Vor Biopharma
Price$2.08
Change-$0.09 (-4.13%)
Volume$7.54K
Capitalization261.17M
CVAC vs VOR Comparison Chart in %
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. VOR commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a Hold and VOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (CVAC: $5.45 vs. VOR: $2.09)
Brand notoriety: CVAC and VOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 25% vs. VOR: 8%
Market capitalization -- CVAC: $1.23B vs. VOR: $261.17M
CVAC [@Biotechnology] is valued at $1.23B. VOR’s [@Biotechnology] market capitalization is $261.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileVOR’s FA Score has 0 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • VOR’s FA Score: 0 green, 5 red.
According to our system of comparison, CVAC is a better buy in the long-term than VOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 1 TA indicator(s) are bullish while VOR’s TA Score has 5 bullish TA indicator(s).

  • CVAC’s TA Score: 1 bullish, 5 bearish.
  • VOR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VOR is a better buy in the short-term than CVAC.

Price Growth

CVAC (@Biotechnology) experienced а +0.55% price change this week, while VOR (@Biotechnology) price change was -5.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.54%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +13.42%.

Reported Earning Dates

CVAC is expected to report earnings on Nov 18, 2025.

VOR is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (-0.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVAC($1.23B) has a higher market cap than VOR($261M). VOR YTD gains are higher at: 96.396 vs. CVAC (59.824). CVAC has higher annual earnings (EBITDA): 228M vs. VOR (-118.74M). CVAC has more cash in the bank: 442M vs. VOR (60M). VOR has less debt than CVAC: VOR (30.8M) vs CVAC (37.4M). CVAC has higher revenues than VOR: CVAC (524M) vs VOR (0).
CVACVORCVAC / VOR
Capitalization1.23B261M470%
EBITDA228M-118.74M-192%
Gain YTD59.82496.39662%
P/E Ratio5.88N/A-
Revenue524M0-
Total Cash442M60M737%
Total Debt37.4M30.8M121%
TECHNICAL ANALYSIS
Technical Analysis
CVACVOR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTRBX19.78N/A
N/A
MFS Total Return B
EMECX11.84N/A
N/A
Ashmore Emerging Markets Equity C
LGOVX35.61N/A
N/A
Lord Abbett Growth Opportunities R6
YASLX11.01N/A
N/A
AMG Yacktman Special Opportunities Z
WIAEX39.20-0.47
-1.18%
Wasatch Small Cap Growth Institutional